Yukiko Maeda

Yukiko Maeda, Ph.D., is a Senior Scientist II in the Genetic Medicine Unit at Sanofi, where research focuses on non-viral DNA delivery and vector immunogenicity modulation since January 2022. Prior to Sanofi, Yukiko served as an Instructor at the University of Massachusetts Medical School from August 2010 to January 2022, leading preclinical gene therapy studies for arthritis and evaluating rAAV vector immunogenicity. Yukiko has contributed significantly to microRNA research in rheumatoid arthritis and has also characterized microRNA-218's role in osteoblast differentiation during a postdoctoral fellowship. Early academic work included a Research Associate position at Harvard University, focusing on postnatal bone growth mechanisms. Academic qualifications include a PhD in Medical Science from Tokyo Medical and Dental University, a Master's in Biological Sciences from Nara Institute of Science and Technology, and a Bachelor's in Physics from Ritsumeikan University.